Spyre Therapeutics
SYRE
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.97 | -0.81 | 0.16 | 16.49% |
| Revenue | 2.33M | 0.00 | -2.33M | -100.00% |
WhatIF - Earnings
EPS Beat Expectations by $0.16
Spyre Therapeutics (SYRE:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything